Effectiveness and Tolerability of Eqwilate in Real-life Conditions

Active, not recruitingOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

November 27, 2019

Primary Completion Date

May 11, 2024

Study Completion Date

November 30, 2026

Conditions
VWD - Von Willebrand's Disease
Interventions
BIOLOGICAL

Eqwilate

Eqwilate® is a new generation, albumin-free, high-purity, double virus-inactivated, freezedried concentrate of VWF and FVIII

Trial Locations (9)

14033

Caen Study Site, Caen

35033

Rennes Study Site, Rennes

42055

Saint-Etienne Study Site, Saint-Etienne

75010

Paris Study Site - Lariboisiere, Paris

75015

Paris Study Site - Necker, Paris

76031

Rouen Study Site, Rouen

92141

Clamart Study Site, Clamart

97405

Saint Denis Study Site - Pediatrie, Saint-Denis

Saint Denis Study Site, Saint-Denis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Octapharma

INDUSTRY